Insider Mark Hancock trims PACS Group, Inc. (PACS) stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PACS Group director and ten percent owner Mark Hancock reported a mix of stock sales and a new equity award. On July 6, 2026, he sold 142,163 shares of common stock at a weighted average price of $45.3343 per share. He also sold 12,825 shares on July 2, 2026 at $45.0129 and 6,080 shares on July 1, 2026 at $45.0191, all as open-market transactions under a pre-arranged Rule 10b5-1 trading plan.
Following these trades, Hancock directly held 53,945,816 shares of PACS Group common stock. Separately, on July 1, 2026 he received 4,287 restricted stock units, each convertible into one share of common stock, vesting 100% on the earlier of July 1, 2027 or the next annual meeting, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 161,068 shares ($7,295,867)
Net Sell
4 txns
Insider
Hancock Mark
Role
null
Sold
161,068 shs ($7.30M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 142,163 | $45.3343 | $6.44M |
| Sale | Common Stock | 12,825 | $45.0129 | $577K |
| Grant/Award | Common Stock | 4,287 | $0.00 | -- |
| Sale | Common Stock | 6,080 | $45.0191 | $274K |
Holdings After Transaction:
Common Stock — 53,945,816 shares (Direct, null)
Footnotes (1)
- Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.075 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.88 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold July 6, 2026: 142,163 shares
Shares sold July 2, 2026: 12,825 shares
Shares sold July 1, 2026: 6,080 shares
+3 more
6 metrics
Shares sold July 6, 2026
142,163 shares
Open-market sale at $45.3343 per share
Shares sold July 2, 2026
12,825 shares
Open-market sale at $45.0129 per share
Shares sold July 1, 2026
6,080 shares
Open-market sale at $45.0191 per share
Total shares sold
161,068 shares
Aggregate of three open-market sales
Shares held after transactions
53,945,816 shares
Direct PACS Group common stock ownership post-July 6, 2026 sale
RSUs granted
4,287 RSUs
Award on July 1, 2026, vesting by July 1, 2027 or next annual meeting
Key Terms
Rule 10b5-1 trading plan, restricted stock units ("RSUs"), weighted average price, annual meeting
4 terms
Rule 10b5-1 trading plan regulatory
"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
annual meeting regulatory
"100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
What insider transactions did Mark Hancock report for PACS Group (PACS)?
Mark Hancock reported selling 161,068 PACS Group common shares in three open-market transactions around $45 per share, and receiving 4,287 restricted stock units that may vest into shares if service conditions are met by July 1, 2027 or the next annual meeting.
Did Mark Hancock’s PACS Group (PACS) sales occur under a Rule 10b5-1 trading plan?
Yes. A footnote explains the sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. Such plans schedule trades in advance, indicating these transactions followed a preset trading arrangement rather than ad hoc market timing.
What PACS Group (PACS) equity award did Mark Hancock receive in this Form 4?
He received 4,287 restricted stock units, each convertible into one PACS Group common share upon vesting. The RSUs vest 100% on the earlier of July 1, 2027 or the next annual meeting, assuming Hancock continues to provide service to PACS Group.